Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-044179
Filing Date
2024-11-08
Accepted
2024-11-08 09:20:26
Documents
6
Period of Report
2024-11-08

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 491045
2 formdef14a_001.jpg GRAPHIC 18418
3 formdef14a_007.jpg GRAPHIC 248053
4 formdef14a_008.jpg GRAPHIC 216619
5 image_001.jpg GRAPHIC 52280
6 image_002.jpg GRAPHIC 56567
  Complete submission text file 0001493152-24-044179.txt   1307929
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36199 | Film No.: 241438216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)